Net Loss per Share - Antidilutive Potential Common Shares (Details) |
3 Months Ended | |
|---|---|---|
|
Mar. 31, 2026
shares
|
Mar. 31, 2025
shares
|
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive potential common stock (in shares) | 12,311,923 | 13,691,057 |
| Metromile | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Conversion ratio | 0.05263 | 0.05263 |
| Options to purchase common stock | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive potential common stock (in shares) | 6,842,282 | 9,260,114 |
| Unvested restricted stock | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive potential common stock (in shares) | 5,469,641 | 4,017,974 |
| Warrants for common stock | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive potential common stock (in shares) | 0 | 412,969 |